Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain.

scientific article published on 17 October 2016

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1073/PNAS.1613246113
P932PMC publication ID5098623
P698PubMed publication ID27791151

P50authorClifford J. WoolfQ5132981
Marco SisignanoQ37372310
Ru-Rong JiQ42386007
Natasja de BruinQ59682589
Michael ParnhamQ66952188
P2093author name stringMike Schmidt
Di Liu
Holger Jordan
Gerd Geisslinger
Ruirui Lu
Klaus Scholich
Carlo Angioni
Yannick Schreiber
Jing Suo
Chul-Kyu Park
Dong-Dong Zhang
Martine Hofmann
Sascha Meyer Dos Santos
Sebastian Zinn
Stephan M G Schäfer
Ajay S Yekkirala
Maria Kuzikov
Béla Zimmer
Stephan W Hohman
P2860cites workSynthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and miceQ21132412
Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodentsQ21146964
Interventions for preventing neuropathy caused by cisplatin and related compoundsQ24236661
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesQ24597172
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivoQ28238324
20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channelQ28261243
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptorsQ28264127
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substancesQ28344313
Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesiaQ28582168
Neurogenic Inflammation – The Peripheral Nervous System’s Role in Host Defense and ImmunopathologyQ28972495
Drug-induced prolongation of the QT intervalQ33151147
Prostaglandins and inflammationQ34179727
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trialQ34336573
Antioxidants accelerate lung cancer progression in miceQ34400895
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialQ34403098
Action of epoxyeicosatrienoic acids on cellular functionQ34567484
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissuesQ34663619
Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.Q35452699
Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative MechanismsQ35675208
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCQ35847455
Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and RegulationQ35897768
5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminalsQ35987054
The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4Q36106866
Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammationQ36199024
Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1).Q36350876
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxelQ36862832
Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neuronsQ37094339
Chemotherapy-induced peripheral neuropathy: prevention and treatmentQ37911252
Cellular mechanisms and physiological consequences of redox-dependent signallingQ38214052
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammationQ38736745
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.Q40773486
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesQ42284671
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulationQ42743261
CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitroQ43874398
Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglionQ44178415
A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of painQ44341121
Reactive oxygen species (ROS) play an important role in a rat model of neuropathic painQ45029206
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.Q46054832
The neuropeptide calcitonin gene-related peptide (CGRP) stimulates T cell migration into collagen matricesQ46635643
Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice.Q46883191
Slack channels expressed in sensory neurons control neuropathic pain in mice.Q51015877
Breast cancer: weekly paclitaxel--still preferred first-line taxane for mBC.Q53384579
The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.Q53514776
Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.Q54573883
TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanismQ59558854
P433issue44
P407language of work or nameEnglishQ1860
P921main subjectneuropathic painQ2798704
P304page(s)12544-12549
P577publication date2016-10-17
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleTargeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain
P478volume113

Reverse relations

cites work (P2860)
Q100388930Antinociceptive modulation by the adhesion GPCR CIRL promotes mechanosensory signal discrimination
Q58790284Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
Q55625734Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes.
Q47868681Thermo-Sensitive TRP Channels: Novel Targets for Treating Chemotherapy-Induced Peripheral Pain
Q58697842Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
Q64060383X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activation
Q47570962Zinc Inhibits TRPV1 to Alleviate Chemotherapy-Induced Neuropathic Pain

Search more.